/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | TNONWTenon Medical, Inc. |
|---|---|
| Last close | $0.01close 2026-11-09 |
| Change % | -1.89%close 2026-11-09 |
| Market cap | $3468.6443999999997close 2026-11-09 |
| P/E | loss, no P/E |
| Revenue | $4M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2025-12-31 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 20.4%FY to 2025-12-31 |
| Net income | $-12556000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 Filing10-K · 0001213900-26-035707 · filed 2026-03-27 Open the filing on EDGAR →Open the XBRL payload →CiteTenon Medical, Inc. (TNONW), us-gaap:NetIncomeLoss: -12,556,000 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001213900-26-035707, filed 2026-03-27. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001560293/us-gaap/NetIncomeLoss.json |
| Net margin | -318.4%FY to 2025-12-31 |
| EPS (diluted) | $-1.70⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001213900-26-035707 · filed 2026-03-27 Open the filing on EDGAR →Open the XBRL payload →CiteTenon Medical, Inc. (TNONW), us-gaap:EarningsPerShareDiluted: -1.70 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001213900-26-035707, filed 2026-03-27. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001560293/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 5FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | -13.74FY to 2025-12-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | rep. 08-13 |